Related Experiment Videos
Readmissions after pancreatoduodenectomy
R C van Geenen1, T M van Gulik, O R Busch
1Department of Surgery, Academic Medical Center, Meibergdreef 9, PO Box 22660, 1100 DD Amsterdam, The Netherlands.
The British Journal of Surgery
|October 31, 2001
Summary
Readmission after pancreatoduodenectomy is common, often due to tumor recurrence or surgical issues. While complications from surgery generally have good outcomes, tumor recurrence significantly impacts survival.
Area of Science:
- Surgical Oncology
- Gastroenterology
- Clinical Outcomes Research
Background:
- Pancreatoduodenectomy (PD) is a major surgery with potential for readmission.
- Readmission can be caused by tumor recurrence or complications, affecting patient prognosis.
Purpose of the Study:
- To analyze readmission rates, indications, and outcomes after pancreatoduodenectomy.
- To identify factors influencing survival post-readmission.
Main Methods:
- Retrospective analysis of 283 consecutive pancreatoduodenectomies performed between October 1992 and June 1999.
- Detailed review of readmission indications, treatments, and patient outcomes.
Main Results:
- 38% of patients were readmitted; 60% for tumor recurrence and 44% for surgical complications.
- Tumor recurrence-related readmissions had limited survival (58 days median), especially with ascites.
- Readmissions for surgical complications had a better prognosis with a median hospital-free survival of 1035 days.
Conclusions:
- Readmission after PD is frequent, driven by recurrence or complications.
- Prognosis differs significantly based on readmission cause: poor for recurrence, good for surgical complications.
- Ascites is a negative prognostic indicator for survival after PD.